Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Warrants to Placement Agent and Shareholders' Equity (Unaudited) - USD ($) $ in Thousands |
Previously Reported
Redeemable Convertible Preferred Stock
|
Previously Reported
Common Stock
|
Previously Reported
Non-voting Common Stock
|
Previously Reported
Additional paid-in capital
|
Previously Reported
Accumulated deficit
|
Previously Reported |
Redeemable Convertible Preferred Stock |
Common Stock |
Non-voting Common Stock |
Additional paid-in capital |
Accumulated deficit |
Warrants To Placement Agent |
Total |
Balance at Dec. 31, 2020 |
|
|
|
|
|
|
|
|
|
$ 5,585
|
|
|
[1] |
|
[1] |
$ 2,771
|
|
$ (17,169)
|
|
$ (14,398)
|
|
Balance (in Shares) at Dec. 31, 2020 |
|
|
|
|
|
|
|
|
|
7,731,083
|
|
2,047,641
|
|
1,783,773
|
|
|
|
|
|
|
|
Exercise of options into common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
|
[1] |
|
|
|
[1] |
Exercise of options into common stock (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
2,763
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53
|
|
|
|
53
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,251)
|
|
(5,251)
|
|
Balance at Dec. 31, 2021 |
|
$ 5,585
|
|
[1] |
|
[1] |
$ 2,824
|
$ (22,420)
|
$ (19,596)
|
$ 5,585
|
|
|
[1] |
|
|
2,824
|
|
(22,420)
|
|
(19,596)
|
|
Balance (in Shares) at Dec. 31, 2021 |
|
7,731,083
|
2,050,404
|
|
1,783,773
|
|
|
|
|
773,108
|
[2] |
205,040
|
[2] |
178,377
|
[2] |
|
|
|
|
|
|
Exercise of options into common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
|
[1] |
|
|
|
[1] |
Exercise of options into common stock (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
1,546
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14
|
|
|
|
14
|
|
Share based compensation (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,639)
|
|
(4,639)
|
|
Balance at Mar. 31, 2022 |
|
|
|
|
|
|
|
|
|
$ 5,585
|
|
|
[1] |
|
|
2,838
|
|
(27,059)
|
|
(24,221)
|
|
Balance (in Shares) at Mar. 31, 2022 |
[2] |
|
|
|
|
|
|
|
|
773,108
|
|
206,586
|
|
178,377
|
|
|
|
|
|
|
|
Balance at Dec. 31, 2021 |
|
$ 5,585
|
|
[1] |
|
[1] |
2,824
|
(22,420)
|
(19,596)
|
$ 5,585
|
|
|
[1] |
|
|
2,824
|
|
(22,420)
|
|
(19,596)
|
|
Balance (in Shares) at Dec. 31, 2021 |
|
7,731,083
|
2,050,404
|
|
1,783,773
|
|
|
|
|
773,108
|
[2] |
205,040
|
[2] |
178,377
|
[2] |
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,500)
|
|
Balance at Sep. 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
36,482
|
|
(30,920)
|
|
5,563
|
|
Balance (in Shares) at Sep. 30, 2022 |
[2] |
|
|
|
|
|
|
|
|
|
|
1,731,755
|
|
|
|
|
|
|
|
|
|
Balance at Dec. 31, 2021 |
|
$ 5,585
|
|
[1] |
|
[1] |
2,824
|
(22,420)
|
(19,596)
|
$ 5,585
|
|
|
[1] |
|
|
2,824
|
|
(22,420)
|
|
(19,596)
|
|
Balance (in Shares) at Dec. 31, 2021 |
|
7,731,083
|
2,050,404
|
|
1,783,773
|
|
|
|
|
773,108
|
[2] |
205,040
|
[2] |
178,377
|
[2] |
|
|
|
|
|
|
Exercise of options into common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
5
|
|
|
|
5
|
|
Exercise of options into common stock (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
77,749
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
220
|
|
|
|
220
|
|
Conversion of convertible redeemable preferred stock to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
$ (5,585)
|
|
$ 1
|
|
|
|
5,584
|
|
|
|
5,585
|
|
Conversion of convertible redeemable preferred stock to common stock upon initial public offering (in Shares) |
|
|
|
|
|
|
|
|
|
(7,731,083)
|
|
7,731,083
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
14,675
|
|
|
|
14,675
|
|
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
4,212,500
|
|
|
|
|
|
|
|
|
|
Conversion of convertible loan to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
6,553
|
|
|
|
6,553
|
|
Conversion of convertible loan to common stock upon initial public offering (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
1,638,161
|
|
|
|
|
|
|
|
|
|
Conversion of convertible note to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
3,600
|
|
|
|
3,600
|
|
Conversion of convertible note to common stock upon initial public offering (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
900,096
|
|
|
|
|
|
|
|
|
|
Conversion of warrants to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
3,190
|
|
|
|
3,190
|
|
Conversion of warrants to common stock upon initial public offering (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
797,567
|
|
|
|
|
|
|
|
|
|
Redemption of non-voting common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
|
|
|
[1] |
Redemption of non-voting common stock upon initial public offering (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,783,773)
|
|
|
|
|
|
|
|
Repurchase of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
15
|
|
|
|
15
|
|
Repurchase of common stock (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
(27,699)
|
|
|
|
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,982)
|
|
(10,982)
|
|
Balance at Dec. 31, 2022 |
|
|
$ 1
|
|
|
|
36,666
|
(33,402)
|
3,265
|
|
|
$ 1
|
|
|
|
36,666
|
|
(33,402)
|
|
3,265
|
|
Balance (in Shares) at Dec. 31, 2022 |
|
|
17,379,861
|
|
|
|
|
|
|
|
[2] |
1,737,986
|
[2] |
|
[2] |
|
|
|
|
|
|
Balance at Mar. 31, 2022 |
|
|
|
|
|
|
|
|
|
$ 5,585
|
|
|
[1] |
|
|
2,838
|
|
(27,059)
|
|
(24,221)
|
|
Balance (in Shares) at Mar. 31, 2022 |
[2] |
|
|
|
|
|
|
|
|
773,108
|
|
206,586
|
|
178,377
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14
|
|
|
|
14
|
|
Share based compensation (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of convertible preferred stock to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
$ (5,585)
|
|
$ 1
|
|
|
|
5,584
|
|
|
|
5,585
|
|
Conversion of convertible preferred stock to common stock upon initial public offering (in Shares) |
[2] |
|
|
|
|
|
|
|
|
(773,108)
|
|
773,108
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
14,675
|
|
|
|
14,675
|
|
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
421,250
|
|
|
|
|
|
|
|
|
|
Conversion of convertible loan to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
6,553
|
|
|
|
6,553
|
|
Conversion of convertible loan to common stock upon initial public offering (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
163,816
|
|
|
|
|
|
|
|
|
|
Conversion of convertible note to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
3,600
|
|
|
|
3,600
|
|
Conversion of convertible note to common stock upon initial public offering (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
90,009
|
|
|
|
|
|
|
|
|
|
Conversion of warrants to common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
3,190
|
|
|
|
3,190
|
|
Conversion of warrants to common stock upon initial public offering (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
79,756
|
|
|
|
|
|
|
|
|
|
Redemption of non-voting common stock upon initial public offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
|
|
|
[1] |
Redemption of non-voting common stock upon initial public offering (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
(178,377)
|
|
|
|
|
|
|
|
Repurchase of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
15
|
|
|
|
15
|
|
Repurchase of common stock (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
(2,770)
|
|
|
|
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,654)
|
|
(1,654)
|
|
Balance at Jun. 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
36,469
|
|
(28,713)
|
|
7,757
|
|
Balance (in Shares) at Jun. 30, 2022 |
[2] |
|
|
|
|
|
|
|
|
|
|
1,731,755
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
13
|
|
Share based compensation (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,207)
|
|
(2,207)
|
|
Net comprehensive loss for the period (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at Sep. 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
36,482
|
|
(30,920)
|
|
5,563
|
|
Balance (in Shares) at Sep. 30, 2022 |
[2] |
|
|
|
|
|
|
|
|
|
|
1,731,755
|
|
|
|
|
|
|
|
|
|
Balance at Dec. 31, 2022 |
|
|
$ 1
|
|
|
|
36,666
|
(33,402)
|
3,265
|
|
|
$ 1
|
|
|
|
36,666
|
|
(33,402)
|
|
3,265
|
|
Balance (in Shares) at Dec. 31, 2022 |
|
|
17,379,861
|
|
|
|
|
|
|
|
[2] |
1,737,986
|
[2] |
|
[2] |
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95
|
|
|
|
95
|
|
Share based compensation (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
(50)
|
|
|
|
(50)
|
|
Repurchase of common stock (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
(7,920)
|
|
|
|
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,895)
|
|
(1,895)
|
|
Net comprehensive loss for the period (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at Mar. 31, 2023 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
36,711
|
|
(35,297)
|
|
1,415
|
|
Balance (in Shares) at Mar. 31, 2023 |
[2] |
|
|
|
|
|
|
|
|
|
|
1,730,066
|
|
|
|
|
|
|
|
|
|
Balance at Dec. 31, 2022 |
|
|
$ 1
|
|
|
|
$ 36,666
|
$ (33,402)
|
$ 3,265
|
|
|
$ 1
|
|
|
|
36,666
|
|
(33,402)
|
|
3,265
|
|
Balance (in Shares) at Dec. 31, 2022 |
|
|
17,379,861
|
|
|
|
|
|
|
|
[2] |
1,737,986
|
[2] |
|
[2] |
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,355)
|
|
Balance at Sep. 30, 2023 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
38,594
|
|
(37,757)
|
104
|
838
|
|
Balance (in Shares) at Sep. 30, 2023 |
[2] |
|
|
|
|
|
|
|
|
|
|
2,694,179
|
|
|
|
|
|
|
|
|
|
Balance at Mar. 31, 2023 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
36,711
|
|
(35,297)
|
|
1,415
|
|
Balance (in Shares) at Mar. 31, 2023 |
[2] |
|
|
|
|
|
|
|
|
|
|
1,730,066
|
|
|
|
|
|
|
|
|
|
Exercise of options into common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
10
|
|
|
|
10
|
|
Exercise of options into common stock (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
10,652
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97
|
|
|
|
97
|
|
Share based compensation (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
1,356
|
|
|
104
|
1,356
|
|
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
190,000
|
|
|
|
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,593)
|
|
(1,593)
|
|
Net comprehensive loss for the period (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at Jun. 30, 2023 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
38,174
|
|
(36,890)
|
104
|
1,285
|
|
Balance (in Shares) at Jun. 30, 2023 |
[2] |
|
|
|
|
|
|
|
|
|
|
1,930,718
|
|
|
|
|
|
|
|
|
|
Exercise of options into common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
|
[1] |
|
|
|
[1] |
Exercise of options into common stock (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
8,791
|
|
|
|
|
|
|
|
|
|
Share based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106
|
|
|
|
106
|
|
Share based compensation (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of pre-funded warrants into common stock |
|
|
|
|
|
|
|
|
|
|
|
|
[1] |
|
|
|
[1] |
|
|
|
[1] |
Exercise of pre-funded warrants into common stock (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
754,670
|
|
|
|
|
|
|
|
|
|
Reclassification of warrants from liabilities to equity (see note (11(d)) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
314
|
|
|
|
314
|
|
Reclassification of warrants from liabilities to equity (see note (11(d)) (in Shares) |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(867)
|
|
(867)
|
|
Net comprehensive loss for the period (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at Sep. 30, 2023 |
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
$ 38,594
|
|
$ (37,757)
|
$ 104
|
$ 838
|
|
Balance (in Shares) at Sep. 30, 2023 |
[2] |
|
|
|
|
|
|
|
|
|
|
2,694,179
|
|
|
|
|
|
|
|
|
|
|
|